Should excessive worry be required for a diagnosis of generalized anxiety disorder? Results from the US National Comorbidity Survey Replication
- PMID: 16300690
- PMCID: PMC1895923
- DOI: 10.1017/S0033291705005908
Should excessive worry be required for a diagnosis of generalized anxiety disorder? Results from the US National Comorbidity Survey Replication
Abstract
Background: Excessive worry is required by DSM-IV, but not ICD-10, for a diagnosis of generalized anxiety disorder (GAD). No large-scale epidemiological study has ever examined the implications of this requirement for estimates of prevalence, severity, or correlates of GAD.
Method: Data were analyzed from the US National Comorbidity Survey Replication, a nationally representative, face-to-face survey of adults in the USA household population that was fielded in 2001-2003. DSM-IV GAD was assessed with Version 3.0 of the WHO Composite International Diagnostic Interview. Non-excessive worriers meeting all other DSM-IV criteria for GAD were compared with respondents who met full GAD criteria as well as with other survey respondents to consider the implications of removing the excessiveness requirement.
Results: The estimated lifetime prevalence of GAD increases by approximately 40% when the excessiveness requirement is removed. Excessive GAD begins earlier in life, has a more chronic course, and is associated with greater symptom severity and psychiatric co-morbidity than non-excessive GAD. However, non-excessive cases nonetheless evidence substantial persistence and impairment of GAD, high rates of treatment-seeking, and significantly elevated co-morbidity compared with respondents without GAD. Non-excessive cases also have sociodemographic characteristics and familial aggregation of GAD comparable to excessive cases.
Conclusions: Individuals who meet all criteria for GAD other than excessiveness have a somewhat milder presentation than those with excessive worry, yet resemble excessive worriers in a number of important ways. These findings challenge the validity of the excessiveness requirement and highlight the need for further research into the optimal definition of GAD.
Figures
Similar articles
-
Generalized anxiety disorder with and without excessive worry in Hong Kong.Depress Anxiety. 2009;26(10):956-61. doi: 10.1002/da.20578. Depress Anxiety. 2009. PMID: 19496076
-
Broadening the definition of generalized anxiety disorder: effects on prevalence and associations with other disorders in the National Comorbidity Survey Replication.J Anxiety Disord. 2007;21(5):662-76. doi: 10.1016/j.janxdis.2006.10.004. Epub 2006 Nov 21. J Anxiety Disord. 2007. PMID: 17118626 Free PMC article.
-
Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions.Psychol Med. 2005 Dec;35(12):1747-59. doi: 10.1017/S0033291705006069. Epub 2005 Oct 5. Psychol Med. 2005. PMID: 16202187
-
Overview of generalized anxiety disorder: epidemiology, presentation, and course.J Clin Psychiatry. 2009;70 Suppl 2:4-9. J Clin Psychiatry. 2009. PMID: 19371500 Review.
-
The epidemiology of generalized anxiety disorder.Psychiatr Clin North Am. 2001 Mar;24(1):19-39. doi: 10.1016/s0193-953x(05)70204-5. Psychiatr Clin North Am. 2001. PMID: 11225507 Review.
Cited by
-
Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders.Expert Rev Neurother. 2009 Aug;9(8):1147-58. doi: 10.1586/ern.09.37. Expert Rev Neurother. 2009. PMID: 19673604 Free PMC article. Review.
-
A community epidemiological survey of generalized anxiety disorder in Hong Kong.Community Ment Health J. 2007 Aug;43(4):305-19. doi: 10.1007/s10597-006-9077-0. Epub 2007 Mar 1. Community Ment Health J. 2007. PMID: 17333348
-
Clinical Significance of Individual GAD Symptoms in Later Life.J Geriatr Psychiatry Neurol. 2016 Mar;29(2):92-8. doi: 10.1177/0891988715606231. Epub 2015 Sep 16. J Geriatr Psychiatry Neurol. 2016. PMID: 26377852 Free PMC article.
-
Epidemiology of anxiety disorders: from surveys to nosology and back.Dialogues Clin Neurosci. 2017 Jun;19(2):127-136. doi: 10.31887/DCNS.2017.19.2/dstein. Dialogues Clin Neurosci. 2017. PMID: 28867937 Free PMC article. Review.
-
Culture and the anxiety disorders: recommendations for DSM-V.Depress Anxiety. 2010 Feb;27(2):212-29. doi: 10.1002/da.20647. Depress Anxiety. 2010. PMID: 20037918 Free PMC article. Review.
References
-
- Abel JL, Borkovec TD. Generalizability of DSM-III-R generalized anxiety disorders to proposed DSM-IV criteria and cross-validation of proposed changes. Journal of Anxiety Disorders. 1995;9:303–315.
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, (DSM-III-R) 3. American Psychiatric Association; Washington, DC: 1987. Revised.
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, (DSM-IV) 4. American Psychiatric Association; Washington, DC: 1994.
-
- Andreasen NC, Endicott J, Spitzer RL, Winokour G. The family history method using diagnostic criteria: reliability and validity. Archives of General Psychiatry. 1977;34:1229–1235. - PubMed
-
- Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Borkovec TD, Rickels K, Stein DJ, Wittchen HU. Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. Journal of Clinical Psychiatry. 2001;62:53–58. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous